These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30811629)

  • 41. Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.
    Deinlein T; Lax SF; Schwarz T; Giuffrida R; Schmid-Zalaudek K; Zalaudek I
    Eur J Cancer; 2017 Sep; 83():99-102. PubMed ID: 28734147
    [No Abstract]   [Full Text] [Related]  

  • 42. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
    Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
    Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma.
    Ivashko IN; Kolesar JM
    Am J Health Syst Pharm; 2016 Feb; 73(4):193-201. PubMed ID: 26843495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    García-Pedrero JM; Martínez-Camblor P; Diaz-Coto S; Munguia-Calzada P; Vallina-Alvarez A; Vazquez-Lopez F; Rodrigo JP; Santos-Juanes J
    J Am Acad Dermatol; 2017 Sep; 77(3):527-533. PubMed ID: 28716437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases.
    Blum V; Müller B; Hofer S; Pardo E; Zeidler K; Diebold J; Strobel K; Brand C; Aebi S; Gautschi O
    Eur J Dermatol; 2018 Feb; 28(1):78-81. PubMed ID: 29336323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of cetuximab in the treatment of squamous cell carcinoma.
    Preneau S; Rio E; Brocard A; Peuvrel L; Nguyen JM; Quéreux G; Dreno B
    J Dermatolog Treat; 2014 Oct; 25(5):424-7. PubMed ID: 23167307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging Nonsurgical Therapies for Locally Advanced and Metastatic Nonmelanoma Skin Cancer.
    Chen L; Aria AB; Silapunt S; Migden MR
    Dermatol Surg; 2019 Jan; 45(1):1-16. PubMed ID: 30045105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Squamous Cell Carcinoma of the Lip-A Review of Squamous Cell Carcinogenesis of the Mucosal and Cutaneous Junction.
    Bota JP; Lyons AB; Carroll BT
    Dermatol Surg; 2017 Apr; 43(4):494-506. PubMed ID: 28157733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of unresectable recurrent cutaneous squamous cell carcinoma of the scalp with meningeal invasion with nivolumab monotherapy.
    Fujimura T; Kambayashi Y; Tono H; Lyu C; Ohuchi K; Hashimoto A; Aiba S
    Dermatol Ther; 2020 Jul; 33(4):e13672. PubMed ID: 32449226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.
    Jarkowski A; Hare R; Loud P; Skitzki JJ; Kane JM; May KS; Zeitouni NC; Nestico J; Vona KL; Groman A; Khushalani NI
    Am J Clin Oncol; 2016 Dec; 39(6):545-548. PubMed ID: 24879468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy.
    Shi VJ; Rodic N; Gettinger S; Leventhal JS; Neckman JP; Girardi M; Bosenberg M; Choi JN
    JAMA Dermatol; 2016 Oct; 152(10):1128-1136. PubMed ID: 27411054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dichotomic response patterns to PD-1 blockade with cemiplimab in a patient with multiple squamous cell carcinomas.
    Bazzacco G; Zelin E; Toffoli L; Conforti C; di Meo N; Fedele D; Zalaudek I
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e547-e549. PubMed ID: 36305888
    [No Abstract]   [Full Text] [Related]  

  • 53. Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.
    Prat A; Navarro A; Paré L; Reguart N; Galván P; Pascual T; Martínez A; Nuciforo P; Comerma L; Alos L; Pardo N; Cedrés S; Fan C; Parker JS; Gaba L; Victoria I; Viñolas N; Vivancos A; Arance A; Felip E
    Cancer Res; 2017 Jul; 77(13):3540-3550. PubMed ID: 28487385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic therapy for advanced cutaneous squamous cell carcinoma.
    Fitzgerald K; Tsai KK
    Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
    Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
    Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel.
    Mecca C; Ponzetti A; Caliendo V; Ciuffreda L; Lista P
    Eur J Dermatol; 2012; 22(6):758-61. PubMed ID: 23131415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.
    Jansen P; Lodde GC; Wetter A; Welt A; Stuschke M; Dührsen U; Stoffels I; Klode J; Livingstone E; Zimmer L; Roesch A; Hadaschik E; Griewank KG; Schadendorf D; Ugurel S
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():41-44. PubMed ID: 34855243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case of advanced pulmonary squamous cell carcinoma cured by resection through preoperative induction of immune checkpoint inhibitor.
    Kawai H; Saito Y; Demura R; Odaka H; Takahashi S; Takahashi K; Kurokawa H; Enomoto K
    Thorac Cancer; 2018 Apr; 9(4):495-497. PubMed ID: 29418077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.
    Ríos-Viñuela E; Álvarez P; Lavernia J; Serra-Guillén C; Requena C; Bernia E; Diago A; Llombart B; Sanmartín O
    Actas Dermosifiliogr; 2022 Jun; 113(6):T610-T615. PubMed ID: 35525283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.